World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
20951
World Ranking
19383
National Ranking
781

Overview

V. De Stefano is affiliated with the Catholic University of the Sacred Heart in Italy. Their research is primarily situated within the field of Medicine, with a strong focus on Hematology, Genetics, Molecular Biology, Oncology, and Rheumatology. The scientist has contributed extensively to understanding various hematologic disorders and treatments.

The main topics of their work encompass:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Eosinophilic Disorders and Syndromes
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Protein Degradation and Inhibitors
  • Kruppel-like factors research

De Stefano's research outputs include numerous publications across prominent journals. Frequent publication venues for their work are:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • Blood Cancer Journal
  • American Journal of Hematology

Collaborations have been notable with multiple co-authors, including:

  • Alessandro M. Vannucchi
  • Elena Rossi
  • Tiziano Barbui
  • Francesca Palandri
  • Paola Guglielmelli

Selected recent papers authored or co-authored by De Stefano illustrate their engagement with clinical trials and real-life studies related to hematologic diseases:

  • Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial (2020) - The Lancet Haematology
  • LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma (2022) - Leukemia
  • Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study (2023) - The Lancet
  • Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial (2021) - The Lancet Haematology
  • Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients (2020) - British Journal of Haematology

Best Publications

  • Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Giorgina Specchia;Rossella Cacciola

  • Inherited thrombophilia: pathogenesis, clinical syndromes, and management.

    V De Stefano;G Finazzi;PM Mannucci

  • The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

    V De Stefano;I Martinelli;P M Mannucci;K Paciaroni

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls

    Joseph Emmerich;Frits R. Rosendaal;Marco Cattaneo;Maurizio Margaglione

  • Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

    Michele Cavo;Lucia Pantani;Maria Teresa Petrucci;Francesca Patriarca

  • Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

    Valerio De Stefano;Tommaso Za;Elena Rossi;Alessandro M. Vannucchi

  • Prothrombin G20210A Mutant Genotype Is a Risk Factor for Cerebrovascular Ischemic Disease in Young Patients

    Valerio De Stefano;Patrizia Chiusolo;Katia Paciaroni;Ida Casorelli

  • Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

    Francesco Zaja;Michele Baccarani;Patrizio Mazza;Monica Bocchia

  • A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

    F Passamonti;T Giorgino;B Mora;P Guglielmelli

  • The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.

    V. De Stefano;F. Sorà;E. Rossi;P. Chiusolo

  • Epidemiology of factor V Leiden: clinical implications.

    V De Stefano;P Chiusolo;K Paciaroni;G Leone

  • Screening for inherited thrombophilia: indications and therapeutic implications

    V De Stefano;E Rossi;K Paciaroni;G Leone

  • Inherited Thrombophilia and First Venous Thromboembolism during Pregnancy and Puerperium

    Ida Martinelli;Valerio De Stefano;Emanuela Taioli;Katia Paciaroni

  • Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.

    V. De Stefano;A. Fiorini;E. Rossi;T. Za

  • Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia.

    T Barbui;A M Vannucchi;V Buxhofer-Ausch;V De Stefano

  • Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial.

    Maria-Victoria Mateos;Hareth Nahi;Wojciech Legiec;Sebastian Grosicki

  • Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry

    Walter Ageno;Nicoletta Riva;Sam Schulman;Jan Beyer-Westendorf

  • Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S

    V De Stefano;G Leone;S Mastrangelo;A Tripodi

Frequent Co-Authors

Giuseppe Leone
Giuseppe Leone Catholic University of the Sacred Heart
Livio Pagano
Livio Pagano Catholic University of the Sacred Heart
Sergio Rutella
Sergio Rutella Nottingham Trent University
Pellegrino Musto
Pellegrino Musto University of Bari Aldo Moro
David Lane
David Lane Imperial College London
Maurizio Margaglione
Maurizio Margaglione University of Foggia
Paola Guglielmelli
Paola Guglielmelli University of Florence
Walter Ageno
Walter Ageno University of Insubria
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Alessandro Rambaldi
Alessandro Rambaldi University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your medical or healthcare career beyond a traditional MD? Online degree programs are making it more accessible to earn advanced qualifications while balancing work and life commitments. An affordable mha online programs option can help you build the skills needed to move into healthcare management, overseeing hospitals, clinics, or health systems.

For nursing professionals, the best online bsn to dnp programs offer opportunities to reach a clinical doctorate level, paving the way for leadership and advanced practice roles.

Aspiring pharmacists can look into pharm d online programs to obtain their doctorate, a crucial credential for pharmacy careers across settings.

Additionally, a health information management degree online can equip you for the evolving intersection between healthcare and technology, opening doors to roles in data analysis, records management, and health IT.

Each pathway offers unique opportunities and flexibility, allowing you to tailor your career to your interests, time, and educational goals.

Best Scientists Citing V. De Stefano

Trending Scientists

Recently Published Articles